AUROLIFE PHARMA LLC FDA Approval ANDA 201013

ANDA 201013

AUROLIFE PHARMA LLC

FDA Drug Application

Application #201013

Application Sponsors

ANDA 201013AUROLIFE PHARMA LLC

Marketing Status

Prescription001
Prescription002
Prescription003

Application Products

001TABLET;ORAL325MG;5MG0HYDROCODONE BITARTRATE AND ACETAMINOPHENACETAMINOPHEN; HYDROCODONE BITARTRATE
002TABLET;ORAL325MG;7.5MG0HYDROCODONE BITARTRATE AND ACETAMINOPHENACETAMINOPHEN; HYDROCODONE BITARTRATE
003TABLET;ORAL325MG;10MG0HYDROCODONE BITARTRATE AND ACETAMINOPHENACETAMINOPHEN; HYDROCODONE BITARTRATE

FDA Submissions

N/A; Not ApplicableORIG1AP2012-04-11
LABELING; LabelingSUPPL3AP2013-10-25STANDARD
LABELING; LabelingSUPPL4AP2016-12-15STANDARD
LABELING; LabelingSUPPL5AP2016-12-16STANDARD
LABELING; LabelingSUPPL6AP2016-12-16STANDARD
LABELING; LabelingSUPPL7AP2017-06-01STANDARD
REMS; REMSSUPPL11AP2018-09-18
LABELING; LabelingSUPPL12AP2018-09-20STANDARD
LABELING; LabelingSUPPL13AP2019-10-11STANDARD
LABELING; LabelingSUPPL14AP2021-03-04STANDARD

Submissions Property Types

ORIG1Null7
SUPPL3Null7
SUPPL4Null15
SUPPL5Null15
SUPPL6Null15
SUPPL7Null7
SUPPL11Null4
SUPPL12Null15
SUPPL13Null15
SUPPL14Null15

TE Codes

001PrescriptionAA
002PrescriptionAA
003PrescriptionAA

CDER Filings

AUROLIFE PHARMA LLC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 201013
            [companyName] => AUROLIFE PHARMA LLC
            [docInserts] => ["",""]
            [products] => [{"drugName":"HYDROCODONE BITARTRATE AND ACETAMINOPHEN","activeIngredients":"ACETAMINOPHEN; HYDROCODONE BITARTRATE","strength":"325MG;5MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"HYDROCODONE BITARTRATE AND ACETAMINOPHEN","activeIngredients":"ACETAMINOPHEN; HYDROCODONE BITARTRATE","strength":"325MG;7.5MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"HYDROCODONE BITARTRATE AND ACETAMINOPHEN","activeIngredients":"ACETAMINOPHEN; HYDROCODONE BITARTRATE","strength":"325MG;10MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"04\/11\/2012","submission":"ORIG-1","actionType":"Approval","submissionClassification":"Not Applicable","reviewPriority":"","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => [{"actionDate":"10\/11\/2019","submission":"SUPPL-13","supplementCategories":"Labeling-Medication Guide, Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."},{"actionDate":"09\/20\/2018","submission":"SUPPL-12","supplementCategories":"Labeling-Medication Guide, Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."},{"actionDate":"09\/18\/2018","submission":"SUPPL-11","supplementCategories":"REMS - PROPOSAL - D-N-A","inserts":"[]","notes":"> Label is not available on this site."},{"actionDate":"06\/01\/2017","submission":"SUPPL-7","supplementCategories":"Labeling-Medication Guide, Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."},{"actionDate":"12\/16\/2016","submission":"SUPPL-6","supplementCategories":"Labeling-Medication Guide, Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."},{"actionDate":"12\/16\/2016","submission":"SUPPL-5","supplementCategories":"Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."},{"actionDate":"12\/15\/2016","submission":"SUPPL-4","supplementCategories":"Labeling-Package Insert, Labeling-Container\/Carton Labels","inserts":"[]","notes":"> Label is not available on this site."},{"actionDate":"10\/25\/2013","submission":"SUPPL-3","supplementCategories":"Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."}]
            [actionDate] => 2019-10-11
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.